The
World Health Organization (WHO) is revising its guidance on non-sterile
processing validation. The guidance is titled “Revision of the Supplementary
Guidelines on Good manufacturing Practice: Non-sterile process validation.”
The
process of updating began in 2013. In August 2014 a new draft was circulated
for comments. The final version is expected early in 2015.
Process
validation data should be generated for all products to demonstrate the
adequacy of the manufacturing process. The validation should be carried out in
accordance with GMP and data should be held at the manufacturing location
whenever possible and be available for inspection.
Central
to the guidance is risk assessment, as the guidance states: “risk-based
approach in validation is recommended. The use of in-line, online and/or
at-line controls and monitoring are recommended to ensure that a process is in
a state of control during manufacture.”
Posted by Tim Sandle
No comments:
Post a Comment
Pharmaceutical Microbiology Resources